Warning: in_array() expects parameter 2 to be array, null given in /home/penny/public_html/wp-content/plugins/quick-adsense-reloaded/includes/post_types.php on line 46
Warning: in_array() expects parameter 2 to be array, null given in /home/penny/public_html/wp-content/plugins/quick-adsense-reloaded/includes/post_types.php on line 46
Ecosphere Technologies and Brasil Clean Energy Sign Agreement for OZONIX SENTINEL(TM) Technology
Ecosphere Approves BCE to Begin Discussions With International Olympic Committee for RIO 2016 Summer Olympic Games
STUART, FL(Marketwired September 29, 2015) Ecosphere Technologies, Inc. (ESPH), a technology development and intellectual property licensing company, today announced that it has signed an exclusive agreement with Brasil Clean Energy (“BCE”), its OZONIX® Licensing partner in Brasil, to begin discussions with municipal and government agencies of Rio de Janeiro to use Ecosphere's recently patented OZONIX SENTINEL” technology to restore the oxygen levels in the bays and lagoons that will be the site of the RIO 2016 Summer Olympic water events. Additionally, Ecosphere has expanded the geographic area for BCE's representation of the Company's patented technologies and products in Brasil to include all of Central and South America. The new agreement calls for Ecosphere and BCE to form a Joint Venture to manufacture Ecosphere's patented technologies in Brasil, as well as other South American countries.
Ecosphere's patented OZONIX® technology and more specifically its latest approved U.S. Patent No. 8,999,154, provides customers with a cost-effective and environmentally-friendly process for treating high-volumes of contaminated water in lakes, rivers, lagoons and estuaries that have been contaminated as a result of manmade and natural events.
José Fernando Gasparotto, Corporate Account Director of BCE, stated, “We are very pleased that Ecosphere has trusted our team with having the responsibility and opportunity to introduce the recently patented OZONIX SENTINEL” technology to the various municipal, government, environmental organizations and Olympic Committee for the 2016 Summer Olympic Games in Rio de Janeiro. The OZONIX SENTINEL” technology is the right technology, at the right time to help restore and protect the vital water resources in Brasil's lakes, bays, and lagoons.”
Magno Escalissi Damasceno, Chief Executive Officer of BCE stated, “Ecosphere is really an excellent innovative technology provider and a perfect partner who will surely be helping in Brasil, not only the cleaning of ponds and lakes, but also segments that today are suffering with lack of good solutions to clean waste water. In October we will be together starting up various pilot programs in Santa Catarina with our first Ozonix EF10M Ecosphere delivered to BCE to clean about 20 types of waste water, including: – municipal sewage, polluted river, polluted pond, hospital sewage, shrimp's processing sewage, silted pond, pork's creation sewage, digestato, chicken processing sewage, cattle slaughter, pig slaughter, dairy effluent, spice effluent, textile effluent, dyeing wastewater, paper mill waste water, sardine processing sewage, and vinasse. We strongly believe that Ecosphere and BCE will be offering to the Brasilian market an excellent cost effective solution to clean and recycle wastewater.”
World-Renown Ocean Explorer, Environmentalist and Ecosphere Board Member Emeritus, Jean-Michel Cousteau, stated, “It is my honor to be working with Ecosphere Technologies and BCE to help restore the vitality of the bays and lagoons in Brasil for the RIO 2016 Summer Olympic Games. There are no more borders. I think we need to understand that there is only one ocean — one water system — and, if you ski or drink a glass of water, you are skiing on the ocean or drinking the ocean. We all depend on the quality of that water for the quality of our lives. The patented Ozonix technology is a proven method to raise the oxygen level in treated waters so that bacteria and algae can't live and overtake the ecosystem.”
Dennis McGuire, Chairman and CEO of Ecosphere Technologies, stated, “Our BCE partners in Brasil have not only spent their lifetimes in the food and beverage industry in South America, but are committed environmental stewards of Brasil. Jean-Michel Cousteau was the first person to represent the Environment in the Olympic Games, carrying the flag in the opening ceremonies of the 2002 Winter Olympic Games in Salt Lake City,and has dedicated his life to protecting the worlds oceans. We have assembled a world-class team to bring our recently patented OZONIX SENTINEL” technology to Brasil to assist them in protecting the Olympic athletes that participate in the summer water events and to also protect their vital water resources.”
Companies of Interest:
|Companies of Interest included in|
this publication are derived from the numerous sources and screens we use
on a routine basis to select our focus companies featured in our monthly
newsletter the Emerging Growth News. While we have only
briefly reviewed these companies, something caught our attention and in
our opinion the company warrants further inspection.
|U.S. Geothermal, Inc. (HTM:NYSE MKT) $0.67 9/17/2015|
U.S. Geothermal, Inc. constructs, manages, and operates power plants that utilize geothermal resources in the Western United States. The company is trading at 7.23 times trailing earnings, 2.16 times sales, 0.78 times book, $71 million market cap., $151 million enterprise value and has $0.12 per share in cash. The company has recently broken out to a new trading range. We intend to open a position in the $0.60 to $0.65 range.
|Dynasil Corporation (DYSL:NASDAQ) $1.61 8/21/2015|
Dynasil Corporation of America develops, manufactures, and markets detection, sensing, and analysis technology products for medical, industrial, and homeland security/defense sectors in the United States and internationally.The company is trading at 0.62 times sales, 1.69 times book, $26.6 million market cap., $30.8 million enterprise value and has $0.21 per share in cash. The company has recently broken out to a new trading range. We intend to open a position in the $1.45 to $1.60 range.
|SmartPros Limited (SPRO:NASDAQ) $2.47 8/20/2015|
SmartPros Ltd. provides learning and educational solutions for accounting/finance, legal, engineering, securities, and insurance markets. The company is trading at 0.80 times sales, 1.41 times book, $11.3 million market cap., $7.3 million enterprise value and has $0.89 per share in cash. The company has recently broken out to a new trading range and pays a 2.8% dividend yield. We intend to open a position in the $1.50 to $1.75 range.
|Photronics, Inc. (PLAB:NASDAQ) $9.42 5/15/2015|
Photronics, Inc., together with its subsidiaries, manufactures and sells photomasks in the United States. The company is trading at 21.6 times trailing earnings, 14.95 times forward earnings, 1.28 times sales, 0.99 times book, 2.20 PEG ratio, $625 million market cap., $540 million enterprise value and has $2.54 per share in cash. The company has recently broken out to a new trading range. We intend to open a position in the $8.75 to $9.25 range.
|Scotts Liquid Gold, Inc. (SLGD:OTCQB) $1.04 4/24/2015|
Scotts Liquid Gold-Inc., through its subsidiaries, develops, manufactures, markets, and sells household products, and skin and hair care products in the United States and internationally. The company is trading at 5.78 times trailing earnings, 0.50 times sales, 1.25 times book, 1.14 PEG ratio, $12 million market cap., $6 million enterprise value and has $0.51 per share in cash. The company has recently broken out to a new trading range. We intend to open a position in the $0.90 to $1.05 range.
|SORL Auto Parts, Inc. (SORL:NASDAQ) $4.42 4/23/2015|
SORL Auto Parts, Inc. develops, manufactures, and distributes automotive brake systems and other safety related auto parts. The company is trading at 6.23 times trailing earnings, 0.36 times sales, 0.43 times book, 1.14 PEG ratio, $85 million market cap., $36 million enterprise value and has $2.53 per share in cash. The company has recently broken out to a new trading range. We intend to open a position in the $3.75 to $4.25 range.
|inTest Corp. (INTT:NYSE MKT) $4.74 4/16/2015|
inTEST Corporation designs, manufactures, and sells thermal, mechanical, and electrical products for use in the testing of integrated circuits (ICs) worldwide. The company is trading at 14.36 times trailing earnings, 11.02 times forward earnings, 1.18 times sales, 1.43 times book, $50 million market cap., $22 million enterprise value and has $2.21 per share in cash. The company has recently broken out to a new trading range. We intend to open a position in the $4.30 to $4.50 range.
|BSQUARE Corp. (BSQR:NASDAQ) $4.58 2/19/2015|
BSQUARE Corporation provides software solutions and related engineering services to companies that develop smart connected systems in North America, Asia, Europe, and internationally. The company is trading at 57.25 times trailing earnings, 0.56 times sales, 2.01 times book, $53 million market cap., $28 million enterprise value and has $2.15 per share in cash. The company has recently broken out to a new 12-month high. We intend to open a position in the $4.00 to $4.60 range.
|Glu Mobile, Inc. (GLUU:NASDAQ) $3.84 2/5/2015|
Glu Mobile Inc. develops and publishes a portfolio of action/adventure and casual games for the smartphones and tablet devices users.Sales were up 109% and the company posted a profit versus a loss over the same period last year (as reported in the most recent quarter), it is trading at 106 times trailing earnings, 11.64 times forward earnings, 2.09 times sales, 2.29 times book, $0.51 per share in cash, $410 million market cap., $356.42 million enterprise value. We intend to open a position in the $3.50 to $4.00 range.
|Synergetics USA, Inc. (SURG:NASDAQ) $4.39 12/26/2014|
Synergetics USA, Inc., a medical device company, provides precision surgical devices, surgical equipment, and consumables primarily for the ophthalmology and neurosurgery markets in the United States and internationally. The company is trading at 39.9 times trailing earnings, 16.88 times forward earnings, 1.71 times sales, 1.73 times book, $111 million market cap., $66 million enterprise value and has $0.81 per share in cash. The company has recently broken out to a new 12-month high. We intend to open a position in the $3.75 to $4.00 range.
Under $5.00 Hitting 12 Month Highs:
Under $5.00 With Significant Insider Buying:
to Focus List Companies:
|Companies included in WSR's Focus List are|
a compilation of WSR's Featured Companies and the companies included in
its model Microcap Portfolio.
Sponsors or Featured Companies:
|Adamis Pharmaceuticals, Inc.|
Adamas Pharmaceuticals, Inc. is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system. The company achieves this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone or in fixed-dose combination products. Adamas is currently developing its lead wholly-owned product candidate, ADS-5102, for a complication of Parkinson's disease known as levodopa-induced dyskinesia, or LID, and is evaluating other potential indications. The company's portfolio also includes two approved products developed with Forest. The first is a fixed-dose combination product, Namzaric, and the second is a controlled-release product, Namenda XR. Forest markets both products in the United States under an exclusive license from Adamas.
|Arch Therapeutics, Inc.|
Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as AC5 Surgical Hemostatic Device(TM), is being designed to achieve hemostasis in minimally invasive and open surgical procedures.
|GeoVax Labs, Inc.|
GeoVax Labs, Inc. (OTCQB: GOVX) is a biotechnology company developing vaccines to prevent, and treat, Human Immunodeficiency Virus (HIV) infections. GeoVax's unique, two component vaccine, a recombinant DNA and a recombinant modified vaccinia Ankara (MVA), is designed to stimulate both anti-HIV antibody and anti-HIV T cell immune responses. GeoVax's DNA and MVA vaccines are used in a prime/boost protocol in which priming is done with the DNA and boosting with the MVA. Both the DNA and MVA express the three major proteins of the HIV virus: Gag, Pol, and Env, and produce non-infectious virus-like-particles. GeoVax's vaccines are unique in expressing virus-like particles that display the native form of the trimeric membrane-bound HIV-1 envelope glycoprotein. GeoVax's vaccines are currently being tested in human clinical trials, for both preventive and therapeutic applications. Clinical trials for GeoVax's preventive HIV vaccines have been conducted by the U.S. National Institutes of Health-supported HIV Vaccine Trials Network (HVTN) with funding from the National Institute of Allergy and Infectious Disease (NIAID). Overall, GeoVax's vaccines, in various doses and combinations, have been tested in close to 500 humans.
|Highpower International, Inc.|
Highpower International was founded in 2001 and produces high-quality Nickel-Metal Hydride (Ni-MH) and lithium-based rechargeable batteries used in a wide range of applications such as electric buses, bikes, energy storage systems, power tools, medical equipment, digital and electronic devices, personal care products, and lighting, etc. Highpower's target customers are Fortune 500 companies, and top 10 companies in each vertical segment. With advanced manufacturing facilities located in Shenzhen, Huizhou, and Ganzhou of China, Highpower is committed to clean technology, not only in the products it makes, but also in the processes of production. The majority of Highpower International's products are distributed to worldwide markets mainly in the United States, Europe, China and Southeast Asia.
|Inovio Pharmaceuticals, Inc.|
Inovio is revolutionizing the fight against cancer and infectious diseases. Our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. With an expanding portfolio of cancer immunotherapies and clinical studies, the company is advancing a growing product pipeline. Partners and collaborators include Roche, the University of Pennsylvania, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, US Dept. of Homeland Security, and University of Manitoba.
|Liberator Medical Holdings, Inc.|
Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Approximately 85% of its revenue comes from supplying products to meet the rapidly growing requirements of general medical supplies, personal mobility aids, diabetes, urological, ostomy and mastectomy patients. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
|Midwest Energy Emissions Corp.|
Midwest Energy Emissions Corp. develops and employs patented and proprietary technologies to remove mercury from coal-fired power plant emissions. The U.S. Environmental Protection Agency's (EPA) Mercury and Air Toxic Standards (MATS) rule requires that all coal- and oil-fired power plants in the U.S., larger than 25 mega-watts, must remove roughly 90% of mercury from their emissions starting April 16, 2015. Midwest employs patented technology that has been shown to achieve mercury removal levels compliant with MATS at a significantly lower cost and with less operational impact than currently used methods, while preserving the marketability of fly-ash for beneficial use, a roughly $450mm industry annually. Management estimates that mercury emissions control is a recurring $2-$3 billion opportunity in the U.S. annually, with further international growth expected as countries adopt mercury emissions regulations under the United Nations Minimata Convention on Mercury.
|OncoSec Medical, Inc.|
OncoSec Medical Inc. is a biopharmaceutical company developing its investigational ImmunoPulse intratumoral cancer immunotherapy. OncoSec Medical's core technology is designed to enhance the local delivery and uptake of DNA IL-12 and other DNA-based immune-targeting agents. Clinical studies of ImmunoPulse have demonstrated an acceptable safety profile and preliminary evidence of anti-tumor activity in the treatment of various skin cancers, as well as the potential to initiate a systemic immune response without the systemic toxicities associated with other treatments. OncoSec's lead program evaluating ImmunoPulse for the treatment of metastatic melanoma is currently in Phase 2 development, and is being conducted in collaboration with several prominent academic medical centers. As the company continues to evaluate ImmunoPulse in its current indications, it is also focused on identifying and developing new immune-targeting agents, investigating additional tumor indications, and evaluating combination-based immunotherapy approaches.
|Pulse Beverage Corporation|
Pulse Beverage Corporation is an emerging beverage company that offers a line of great tasting, refreshing, low-calorie natural drinks, including Natural Cabana Lemonade and Limeade, Natural Cabana Coconut Water and Pineapple Coconut Water, and PULSE brand of functional beverages. Combining all-natural ingredients, essential vitamins and minerals, Pulse's line of beverages provides consumers with high-quality, healthy alternatives at a reasonable price.
|Sanomedics International Holdings, Inc.|
Sanomedics International Holdings, Inc. (SIMH) is a medical technology holding company that focuses on game changing products, services and ideas — a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. Sanomedics plans to grow existing business organically and through strategic acquisitions specifically relating to healthcare technology and services. SIMH operates three wholly-owned subsidiaries: Thermomedics, Biscayne Medical and SanoER.
|Small Business Development Group, Inc.|
Small Business Development Group, Inc. (symbol: SBDG) is a current-information Pink company, incorporated in the State of Texas, trading on OTCMarkets.com, structured and operated as a holding company. It was formed in 2013 as a result of the rehabilitation and restructuring of a Virogen, Inc. Its purpose is four-fold: to acquire stable, profitable companies for its portfolio; through its subsidiaries, to provide a range of business and financial services to its portfolio companies, and to other entities, as a profit center; to serve as a test bed for the development and refinement of the premier SBDG business model, ‘the Engineering of a Public Company'; and finally, to provide a vehicle for the spinoff of its mature portfolio silos into Business Development Companies (BDCs), or a stand-alone public or private company thereby creating structured exit strategies and liquidity events for owners and investors.
|Stevia First Corporation|
Stevia First Corp. is an agricultural biotechnology company that has developed expertise for the production of stevia using fermentation and for improvement of traditional stevia farming and processing methods. The Company is also applying breakthrough technologies in software and the life sciences to develop product applications far beyond stevia and the food and beverage industry.
|Vycor Medical, Inc.|
The Company operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach. Both technologies have exceptional sales growth potential, address large potential markets, have the requisite regulatory approvals and are commercialized and generating revenue. Vycor Medical's ViewSite Surgical Access Systems (VBAS) is a suite of clear cylindrical minimally invasive disposable devices that hold the potential for speedier, safer and more economical brain surgeries and a quicker patient discharge. NovaVision develops and provides science-driven neurostimulation therapy and other medical technologies that help improve and partially restore sight in patients with neurological vision impairments. The company's proprietary Visual Restoration Therapy (VRT) platform is clinically supported to improve lost vision resulting from stroke, traumatic brain injury (“TBI”), or other acquired brain injuries.
|Water Technologies Intl., Inc.|
Water Technologies International, Inc., (WTII) is in the business of designing, manufacturing and distributing Atmospheric Water Generators (AWGs) and related products through its subsidiaries Aqua Pure International, Inc. and GR8 Water, Inc. The Company has patent pending products in water generation, air filtration, water filtration and dehumidification. WTII sells and distributes home, office and commercial AWGs units that produce drinking water, ranging from seven gallons to several thousands of gallons per day by extracting water from the air.
For additional information contact:
3545 SW Corporate Parkway
Palm City, FL 34990
Please to from our mailing list.
Confidentiality Note: The information in this message is a legally privileged
Copyright 2014. Wall Street Resources is an emerging growth company specialist, which publishes financial reports with respect to some of the securities that it covers and provides a newsletter, special reports and daily notes focused on micro-to-small capital companies on a subscription basis. The information contained in these publications is based upon sources, which we believe to be reliable, but is in no way warranted by us as to accuracy or completeness. The information contained herein is subject to change without notice, and we assume no responsibility to update the information in our financial publications.
We, our affiliates, and any officer, director or stockholder or any member of their families may have a position in and may from time to time purchase or sell any securities discussed in our financial publications or included in our newsletters. An employee, author, officer, or a director of the firm, or its affiliates, may serve as a director for companies mentioned in our financial publications. There may be instances when fundamental, technical, and quantitative opinions may not be in concert. Our affiliates may from time to time perform investment banking or other services for, or solicit investment banking or other business from, any company mentioned on this web site. While no companies pay a specific fee to be included in our newsletter, daily notes or special reports, certain companies, which are published as featured companies on our website, pay a due diligence fee for participation in the Wall Street Resources' financial publication and distribution program. In compliance with rule 17b of the Securities and Exchange Commission, detailed information regarding compensation from such companies is included on the last page of such reports, is explained in the disclaimer located at http://wallstreetresources.net/disclaimer.html, and is available upon request.
Wall Street Resources, Inc. is not a broker/dealer or registered investment advisor and thus the information on this site is not intended to provide tax, legal or investment advice. The information does not constitute a solicitation of any order to buy or sell any securities. Wall Street Resources, Inc. is a financial publisher and not a broker/dealer or registered investment advisor, and thus all trades and actual trading, decisions are made solely by the individual investor, not by Wall Street Resources, Inc. Wall Street Resources, Inc. and/or the employees of Wall Street Resources, Inc. will not be held responsible for any losses that might occur from the use of the information provided by our newsletter services, or any other information related to Wall Street Resources, Inc. that might be acted upon by an investor. The information provided herein may be displayed and printed for your personal, noncommercial use only. You may not reproduce, retransmit, distribute, disseminate, sell, publish, broadcast or circulate the information to anyone, without the express written consent of Wall Street Resources, Inc.
Wall Street Resources, Inc. is an information provider only. We cannot control market conditions, liquidity, market shutdowns, entry and exit prices, Internet shut-downs, or fax and mail delays. All investors should only invest or trade with capital that is risk capital that they can afford to lose. If emerging growth stock investing or trading seems too risky for you, you might want to consider starting with a less aggressive form of investing, such as the regular mutual fund contributions.